CAS 51411-04-2

Alrestatin

Description:

Alrestatin, with the CAS number 51411-04-2, is a chemical compound that has been studied primarily for its potential therapeutic applications. It is classified as a synthetic compound and is known for its role as an inhibitor of certain biological pathways, particularly in the context of cancer research. Alrestatin exhibits properties that may influence cellular processes, including proliferation and apoptosis, making it a subject of interest in pharmacological studies. The compound's structure includes specific functional groups that contribute to its biological activity, although detailed information about its solubility, stability, and reactivity may vary based on experimental conditions. As with many compounds in drug development, understanding its pharmacokinetics and pharmacodynamics is crucial for evaluating its efficacy and safety in clinical settings. Research continues to explore its potential applications, and ongoing studies may provide further insights into its mechanisms of action and therapeutic benefits.

Formula: C₁₄H₉NO₄

InChI: InChI=1/C14H9NO4/c16-11(17)7-15-13(18)9-5-1-3-8-4-2-6-10(12(8)9)14(15)19/h1-6H,7H2,(H,16,17)

InChI key: InChIKey=GCUCIFQCGJIRNT-UHFFFAOYSA-N

SMILES: O=C1C=2C=3C(C(=O)N1CC(O)=O)=CC=CC3C=CC2

Synonyms:

• (1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetic acid
• 1,3-Dioxo-1H-benz(de)isoquinoline-2(3H)-acetate
• 1,3-Dioxo-1H-benz(de)isoquinoline-2(3H)-acetic acid
• 1H-Benz(de)isoquinoline-2(3H)-acetic acid, 1,3-dioxo-
• 2,3-Dihydro-1,3-dioxo-1H-benz(de)isochiolin-2-essigsaeure
• 2-(1,3-Dioxobenzo[de]isoquinolin-2-yl)acetic acid
• Alrestatin [INN]
• Alrestatine
• Alrestatine [INN-French]
• Alrestatino
• Alrestatino [INN-Spanish]
• Alrestatinum
• Alrestatinum [INN-Latin]
• Ay 22284
• Brn 0244370
• Hic 016G
• Nsc 299132
• Unii-515Dhk15Lg
• [1,3-Dioxo-1H,3H-benz[de]isoquinolin-2-yl]acetic acid
• Alrestatin
• 4-21-00-05562 (Beilstein Handbook Reference)
• (1,3-Dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-acetic acid
• 1,3-Dioxo-1H-benzo[de]isoquinoline-2(3H)-acetic acid
• AURORA 5841
• 1,3-Dioxo-2,3-dihydro-1H-benzo[de]isoquinoline-2-acetic acid
• 2-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetic acid
• 2,3-Dihydro-1,3-dioxo-1H-benzo[de]isoquinoline-2-acetic acid
• 1,3-dioxo-1h-benz(de)isoquinoline-2(3h)-aceticaci
• AKOS BBS-00007376
• 1,3-DIOXO-1H-BENZ[D,E]ISOQUINOLINE-2(3H)-ACETIC ACID

Alrestatin

CAS: 51411-04-2

Formula: C₁₄H₉NO₄

Purity: %

Color and Shape: Solid

Molecular weight: 255.2256

Ref: IN-DA00D9WS

Alrestatin

CAS: 51411-04-2

Alrestatin

Purity: ≥98%

Molecular weight: 255.2256g/mol

Ref: 54-BUP10388

2-(1,3-Dioxo-1H-Benzo[De]Isoquinolin-2(3H)-Yl)Acetic Acid

CAS: 51411-04-2

2-(1,3-Dioxo-1H-Benzo[De]Isoquinolin-2(3H)-Yl)Acetic Acid

Purity: 99%

Molecular weight: 255.23g/mol

Ref: 54-OR1009641

Alrestatin

CAS: 51411-04-2

Alrestatin (AY-22284) is a specific inhibitor of aldose reductase and attenuates glucose-induced angiotensin II production in rat vascular smooth muscle in

Formula: C₁₄H₉NO₄

Purity: 99.23%

Color and Shape: Solid

Molecular weight: 255.2256

Ref: TM-T5195

(1,3-Dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-acetic acid

CAS: 51411-04-2

Formula: C₁₄H₉NO₄

Purity: 98+%

Molecular weight: 255.229

Ref: 10-F494561

Alrestatin

CAS: 51411-04-2

Alrestatin is a molecule that inhibits the activity of enzymes in the reductase family. Alrestatin has been shown to inhibit both reductases and their binding partner, prostaglandin synthase. It also inhibits the formation of pro-inflammatory mediators by inhibiting enzyme activities. Alrestatin has been shown to be effective against nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, and indomethacin.

Formula: C₁₄H₉NO₄

Purity: Min. 95%

Molecular weight: 255.23 g/mol

Ref: 3D-BCA41104